Literature DB >> 9564191

Psychiatric research interview for substance and mental disorders: phenomenologically based diagnosis in patients who abuse alcohol or drugs.

D Hasin1, K Trautman, J Endicott.   

Abstract

The Psychiatric Research Interview for Substance and Mental Disorders (PRISM) is a psychiatric diagnostic interview designed to diagnose DSM-IV substance and mental disorders in patients who abuse alcohol or drugs. Primary disorders tested in the DSM-III-R version of the interview showed improved reliability over existing instruments, and substantially improved reliability for major depressive disorder (MDD). Developments for DSM-IV include a systematic set of procedures for differentiating primary disorders, substance-induced disorders, and the expected effects of intoxication and withdrawal based on the phenomenology of symptoms in conjunction with alcohol and drug use. A longitudinal version of the PRISM provides data on remission and relapse that can be analyzed with survival methods. Pilot and preliminary testing of the DSM-IV and longitudinal versions of the instruments is presented. By making use of psychometric principles, particularly the need to reduce criterion variance, these instruments can clarify some of the longstanding issues in the diagnosis of patients who abuse alcohol and drugs.

Entities:  

Mesh:

Year:  1998        PMID: 9564191

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  19 in total

1.  Stressful life events and suicidal behavior in adults with alcohol use disorders: role of event severity, timing, and type.

Authors:  Kenneth R Conner; Rebecca J Houston; Marc T Swogger; Yeates Conwell; Sungeun You; Hua He; Stephanie A Gamble; Arthur Watts; Paul R Duberstein
Journal:  Drug Alcohol Depend       Date:  2011-08-10       Impact factor: 4.492

Review 2.  Co-occurring disorders in substance abuse treatment: issues and prospects.

Authors:  Patrick M Flynn; Barry S Brown
Journal:  J Subst Abuse Treat       Date:  2007-06-15

3.  Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons.

Authors:  Michael D Stein; Debra S Herman; Malyna Kettavong; Patricia A Cioe; Peter D Friedmann; Tahir Tellioglu; Bradley J Anderson
Journal:  J Subst Abuse Treat       Date:  2010-07-03

4.  Integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders.

Authors:  Daniel William Chandler; Gary Spicer
Journal:  Community Ment Health J       Date:  2006-08-24

Review 5.  Importance of clinical diagnoses for comorbidity studies in substance use disorders.

Authors:  Marta Torrens; Rocío Martin-Santos; Sharon Samet
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

6.  Attendance and substance use outcomes for the Seeking Safety program: sometimes less is more.

Authors:  Denise A Hien; Antonio A Morgan-Lopez; Aimee N C Campbell; Lissette M Saavedra; Elwin Wu; Lisa Cohen; Lesia Ruglass; Edward V Nunes
Journal:  J Consult Clin Psychol       Date:  2011-12-19

7.  Racial/ethnic match and treatment outcomes for women with PTSD and substance use disorders receiving community-based treatment.

Authors:  Lesia M Ruglass; Denise A Hien; Mei-Chen Hu; Aimee N C Campbell; Nathilee A Caldeira; Gloria M Miele; Doris F Chang
Journal:  Community Ment Health J       Date:  2014-05-10

8.  Meta-analysis of depression and substance use and impairment among cocaine users.

Authors:  Kenneth R Conner; Martin Pinquart; Amanda P Holbrook
Journal:  Drug Alcohol Depend       Date:  2008-06-27       Impact factor: 4.492

9.  Neurocognition in individuals co-infected with HIV and hepatitis C.

Authors:  Charles H Hinkin; Steven A Castellon; Andrew J Levine; Terry R Barclay; Elyse J Singer
Journal:  J Addict Dis       Date:  2008

Review 10.  Assessing addiction: concepts and instruments.

Authors:  Sharon Samet; Rachel Waxman; Mark Hatzenbuehler; Deborah S Hasin
Journal:  Addict Sci Clin Pract       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.